Structure Therapeutics is trading at $47.14 (down 4.3%) in a consolidation move following a sharp two-day biotech-led rally.
- The stock previously climbed to $49.47 on July 30 and reached as high as $51.50 in pre-market trading during the sector-wide surge.
- Today’s pullback appears to be a normal technical correction following the recent gains rather than a reaction to new, company-specific news or events.